Announced details
Cell therapy and gene-modified cell therapy for intractable brain tumors, including malignant glioma
In a mouse model of malignant glioma, the survival period of the SHED-OV treatment group was significantly longer than that of the control group. Tumors completely disappeared in 3 mice.
S-Quatre Co., Ltd. and Hamamatsu University School of Medicine conducted joint research. S-Quatre provided SHED. S-Quatre is a group company of Kidswell Bio Corporation.
1-20-1 Handayama, Chuo-ku, Hamamatsu. A national university corporation with departments including neurosurgery.
DOI: 10.1038/s41417-026-01072-1
No impact on business performance stated
The company does not address Contract Value / Offering price.
Cancer Gene Therapy
| Item | Details |
|---|---|
| Names of Products / Services Covered | SHED-OV therapy (oncolytic virus therapy using SHED), SQ-SHED (SHED-based product) |
| Counterparty | Hamamatsu University School of Medicine, National University Corporation |
| Counterparty overview | 1-20-1 Handayama, Chuo-ku, Hamamatsu. A national university corporation with departments including neurosurgery. |
| Relationship with the Company | S-Quatre Co., Ltd. and Hamamatsu University School of Medicine conducted joint research. S-Quatre provided SHED. S-Quatre is a group company of Kidswell Bio Corporation. |
| Applicable area | Cell therapy and gene-modified cell therapy for intractable brain tumors, including malignant glioma |
| Registration number and expiry date | DOI: 10.1038/s41417-026-01072-1 |
| Quantitative Effects | In a mouse model of malignant glioma, the survival period of the SHED-OV treatment group was significantly longer than that of the control group. Tumors completely disappeared in 3 mice. |
| Impact on Business Performance | No impact on business performance stated |
| Source | Cancer Gene Therapy |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To deepen understanding of the characteristics and mechanisms of action of SHED and accumulate knowledge useful for future research and development.